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Abstract: Transposable elements (TEs) are mobile 
DNA elements that represent almost half of the human 
genome. Transposition of TEs has been implicated as a 
source of genome evolution and acquisition of new traits 
but also as an origin of diseases. The activity of these ele-
ments is therefore tightly regulated during the life cycle 
of each individual, and many recent discoveries involved 
the genetic and epigenetic mechanisms in their control. 
In this review, we present recent findings in this field of 
research, focusing on the case of one specific family of 
TEs: the long-interspersed nuclear elements-1 (LINE-1 or 
L1). LINE-1 elements are the most representative class of 
retrotransposons in mammalian genomes. We illustrate 
how these elements are conserved between mice and 
humans, and how they are regulated during the life cycle. 
Additionally, recent advances in genome-wide sequenc-
ing approaches allow us not only to better understand the 
regulation of LINE-1 but also highlight new issues specifi-
cally at the bioinformatics level. Therefore, we discuss the 
state of the art in analyzing such bioinformatics datasets 
to identify epigenetic regulators of repeated elements in 
the human genomes.
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Introduction
Since their discovery by Barbara McClintock in the 1940s 
(1), transposable elements (TEs) still continue to enthuse 
and inspire researchers. Significant progress has been 
made in understanding the biology of TEs, which is 
reflected by the increasing number of published studies. 
The popularity of these classes of DNA stems from their 
ability to translocate to a new location in a genome, 
explaining why TEs are also called ‘jumping genes’ or 
‘mobile elements’. Moreover, TEs account for 46% of the 
human genome (2) and about 39% of the mouse genome 
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(3). They are divided into two classes, according to a clas-
sification proposed by Finnegan in 1989 (4) and revisited 
by Wicker et al. in 2007 (5), based on their mechanism of 
transposition: class I retrotransposons require an RNA 
intermediate involving a ‘copy-and-paste’ mechanism (6) 
and class II DNA transposons move by a ‘cut-and-paste’ 
mechanism (7). Retrotransposons represent about 42% of 
the human and 38% of the mouse genome, whereas DNA 
transposons account for only 3% and 1%, respectively (2, 
3). In this review, we will focus on retrotransposons and 
more specifically on the regulation of long-interspersed 
nuclear elements-1 (LINE-1 or L1), a subclass of this 
family. L1 is the most representative class of retrotrans-
posons in the mammalian genome, representing 17% of 
the human (2) and almost 19% of the mouse genome (3). 
They belong to the autonomous non-LTR retrotranspo-
son category, owing to their ability to encode the proteins 
required for their mobility. L1 elements are about 6–7 kb in 
length and contain a 5′ untranslated region (5′UTR) with 
an internal promoter activity, two open reading frames 
(ORF1 and ORF2), and a 3′UTR that ends with a poly(A) 
tail (Figure 1A). ORF1 encodes a 40 kDa protein with RNA 
binding activity (8), whereas ORF2 encodes a 150 kDa 
protein with a reverse transcriptase (9) and an endonu-
clease domain (10) (Figure 1A). Active L1 elements must be 
able to perform a complete retrotransposition cycle that 
includes the following steps in chronological order: tran-
scription of L1 RNA, export into the cytoplasm, translation 
of ORF1 and ORF2, association of L1 RNA with ORF1 and 
ORF2 proteins to form ribonucleoprotein (RNP) particles 
(11), return to the nucleus, reverse transcription, and inte-
gration at a new genomic location – a one-step process 
also called target primed reverse transcription (TPRT) 
(12) (Figure 1B). During this retrotransposition event, the 
5′UTR is frequently truncated (2) and the L1 sequence is 
prone to inversion (13). These are the two main reasons 
for the accumulation of inactive L1 copies in the genome. 
Indeed, the number of L1 fragments in the human genome 
has been estimated at 516 000 elements (2); however, only 
80–100 of them have kept their mobility capability (14). 
Similarly, the mouse genome contained almost 600  000 
L1 fragments (3); however, previous studies showed that 
only 3000 full-length elements are potentially able to 
retrotranspose (15, 16). These active L1 copies can deeply 
influence the genome in numerous ways, beneficial 
and detrimental (17). L1 retrotransposition can act as a 
5’ UTR ORF 1 ORF 2 3’ UTR
Translation
Transcription
LINE1-RNA
Export
Import
L1ORF1p
L1ORF2p
Ribonucleoprotein
formation
1
Cytoplasm
Nucleus
Ribosome
40 kDa
RNA binding activity
150 kDa
RT + endonuclease activity
2
3
4
6
5
Target primed
reverse transcription
or
mRNA or
Alu-RNA or
SINE-RNA
Cis preferenceTrans complementation
A
B
Figure 1 Schematic representation of L1 structure and retrotransposition cycle.
(A) L1 anatomy – an L1 is composed of a 5′UTR, two ORFs each coding for a protein [ORF1p (40 kDa) and ORF2p (150 kDa)], and a 3′UTR. (B) L1 
retrotransposition cycle – during a complete retrotransposition cycle, an L1 element is transcribed (1) and the resulting L1 RNA is exported 
out of the nucleus into the cytoplasm (2). Then, the bicistronic RNA is translated (3) into ORF1 and ORF2 proteins, which bind the L1-RNA to 
form RNP particles (4): this is the cis preference. ORF1p and ORF2p can also bind other RNAs (such as cellular mRNA, Alu-RNA, or SINE-RNA): 
this is called the trans complementation phenomenon. Finally, RNP complexes are imported into the nucleus (5) where the RNA can be 
integrated at a new genomic location by the process of TPRT (6).
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mutagen by inserting into exons, inducing aberrant splic-
ing or exon skipping by inserting into introns, and less 
commonly, they can give rise to a gene-breaking phenom-
enon (18). This last example could generate distinct tran-
scription units (19), which can lead to sporadic cases of 
diseases (18). Thereby, since their discovery, almost 65 dis-
eases-causing mutations in humans have been attributed 
to L1-mediated retrotransposition. Moreover, L1 elements 
are able to mediate the retrotransposition of other RNAs, 
a phenomenon called trans complementation (Figure 1B). 
In this case, L1 can mobilize non-autonomous retrotrans-
posons such as short interspersed elements (SINEs) and 
Alu elements (20) or process pseudogenes from cellular 
mRNAs (21), and therefore participate in genome expan-
sion (18). Here, however, we will focus on the regulation of 
L1 transcription and retrotransposition, as the impact of 
new L1 insertions on the genome has already been exten-
sively reviewed (12, 17, 18). In humans, the current rate of 
L1 retrotransposition has been estimated between 1 inser-
tion out of 20 and 1 out of 200 live births depending on the 
analysis method (18). L1 elements have been described to 
be expressed in the germ line, during early development 
and in some somatic tissues, as well as in tumor cells (22). 
In this review, we will focus on the regulatory mecha-
nisms involved in the control of these TEs during the life 
cycle in mammals, from gamete precursors to somatic 
cells through the blastocyst stage. Our goal is to provide 
an overview of what is known about L1 regulation itself, 
the latest discoveries in the field, and the tools available 
to analyze such repeat elements. First, we will present a 
comparison of active L1 5′UTR from humans and mice, the 
two main mammalian systems used to study L1 regulation 
in mammals. Subsequently, we will describe the numer-
ous regulatory mechanisms of L1 that are presently known 
and the latest hypothesis. Finally, we will present the 
bioinformatics tools used to study repeated elements as 
well as the problems related to the high number of copies 
present in the genomes. We will conclude our review with 
potential future research directions.
Comparison of human and mouse 
active LINE-1 elements
Numerous studies have been conducted using mouse L1 
constructions in human cell lines and vice versa, and have 
shown that human L1 are able to retrotranspose in the 
mouse, in vitro and in vivo (23, 24). At the same time, other 
studies employ artificial L1 constructions to better under-
stand the mechanisms that can rule their regulation (25, 
26). However, even if mouse and human L1 share common 
features concerning their biology, they also differ on many 
points, putting into question the conservation of the L1 
regulatory mechanisms between the two mammalian 
systems used to study this class of TEs.
Differences in mobilization activity
First, mouse and human genomes differ considerably con-
cerning the number of L1 active copies (27): the percent-
age of active elements according to the number of copies 
in the genome is 25 times higher in mice (0.5%) than in 
humans (0.015–0.020%) (2, 3, 15, 16). This observation sug-
gests a decline of L1 activity in humans. Comparative gene 
expression analysis performed on human and non-human 
primate (NHP) induced pluripotent stem cells revealed reg-
ulation differences of L1 with an increase of their mobility 
in the NHP genomes (28). Regulation differences between 
human and NHPs support the idea that mouse and human 
L1 regulatory mechanisms can diverge as well.
Differences in structure
Furthermore, mouse and human L1 elements also differ in 
their structure: mouse L1 are approximately 7 kb in length 
(17), whereas human L1 are around 6 kb (12). Moreover, 
the two ORFs of human L1 are in frame and separated by 
a 67–70 bp non-coding spacer region containing a stop 
codon in the three reading frames. In mouse, the two ORFs 
are also separated by a spacer region (29–115 bp) (29) and 
they have different reading frames. Finally, unlike human 
L1, the 5′UTR of mouse L1 contains variable numbers of 
monomers, which are tandem repeat units of 205–210 bp 
with an intrinsic promoter activity (30). This allows the 
definition of several L1 subfamilies in the Repbase data-
base (31), among them three are proved to be active in 
mice: A (32), Tf (15), and Gf (16).
Focus on the 5′UTR, a key region for L1 
regulation
L1 5′UTR contains an internal promoter activity independ-
ent of upstream sequences (33), as well as an antisense 
promoter (34–36), making the 5′UTR a key region in the 
regulation of these elements and in the definition of an 
active element. Moreover, human and mouse L1 5′UTR 
have different putative transcription factor (TF) binding 
sites (37). Considering these evidences, we chose to focus 
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on the 5′UTR of active elements to gain deeper insight 
into the comparison between human and mouse L1. As 
we previously mentioned in the Introduction, the human 
genome contains around 80–100 active L1, called retro-
transposition competent L1 (RC_L1) (14). In the literature, 
RC_L1 are also denoted as L1Hs or L1-PA1 (31). It has been 
recently shown that the 5′UTR of RC_L1 could adopt sec-
ondary structures that can be recognized and processed 
by protein complexes (38). Here, we present a compari-
son of the sequences and potential secondary structures 
of 5′UTR from active L1 subfamilies, including A, Tf, and 
Gf in mouse and RC_L1 (Figure 2). To investigate the dif-
ference among these four regions, we considered the con-
sensus sequence of each 5′ UTR element (31) and used two 
different approaches: (i) drawing the phylogenetic tree 
using a neighbor-joining algorithm to reveal the evolution-
ary relation (39) (Figure 2A), and (ii) performing sequences 
and structure alignments by using LocARNA (40) (Figure 
2B). As expected, mouse L1 5′UTR from the different sub-
families clustered into the same group with both methods. 
According to these trees, L1-Tf and L1-Gf 5′UTR appear to be 
the most similar regions, whereas RC_L1 5′UTR is, in both 
cases, the most divergent (Figure 2A,B). Then, we com-
pared the predicted secondary structures of these four L1 
5′UTR by RNAfold (41), and we found a substantial diver-
gence not only between the human and mouse L1 5′UTR 
region but also among the mouse L1 5′UTR subfamilies 
(Figure 2C). These differences suggest that the mechanisms 
involved in the regulation of active mouse and human L1 
can be potentially distinct, even between subfamilies.
L1 regulation during the mammalian 
life cycle
It has been estimated that in humans, one new genomic L1 
insertion appears in every 10–250 individuals and that the 
proportion of L1 retrotransposition causing disease could 
be around 0.07% (12). In mice, the number of active L1 has 
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Figure 2 Sequences and structures comparison of human (RC_L1) and mouse (Gf, Tf, A) L1 5′UTRs.
(A) Phylogenetic tree generated with neighbor-joining algorithms using the Kimura model. The numbers on the nodes indicate the percent-
age of the labeled node present in 93 bootstrap replicates. (B) Multiple sequence and secondary structure alignment by LocARNA. The 
height of the tree corresponds to the LocARNA scores, where lower scores/heights indicate a closer distance. (C) Secondary structures were 
predicted by RNAfold. The color represents the entropy for each base. L1Md Tf 5UTR Mm, Tf mouse L1 subfamily; L1Md A 5UTR Mm, a mouse 
L1 subfamily; L1Md Gf 5UTR Mm, Gf mouse L1 subfamily; RC_L1 5UTR Hs, human retrotransposition competent L1.
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been estimated using cell culture assays to a total of 3100. 
In terms of ratio of active copies per total copies present in 
the genome, the proportion of operational L1 in mice is 25 
times higher than in humans. Owing to their high muta-
genic potential, these elements must be strongly regulated 
during the development and adult life of each individual. 
In this part of the review, we present the state of the art of 
the L1 regulatory mechanisms described in the literature. 
As a guideline, this section is divided according to the 
different steps of the mammalian life cycle; thus, we first 
describe the pathways regulating L1 in the germ line, after 
fertilization and to the blastocyst stage. Subsequently, we 
depict which mechanisms are involved in sustaining the 
control in somatic cells, and finally, we discuss about the 
particular cases of L1 reactivation in somatic cells.
Epigenetic regulation through DNA methylation is one 
the main mechanisms, which has evolved to play a role in 
the defense against TEs through transcriptional silencing 
(42). During the mouse life cycle, L1 promoters undergo 
two waves of partial demethylation: one occurs during 
the specification and migration of primordial germ cells 
(PGCs) and the other during the preimplantation stage 
(43) (Figure 3A). However, DNA methylation is not the only 
L1 repressor system used to control their transcription and 
retrotransposition. Therefore, it has been proposed that 
overlapping epigenetic mechanisms evolved to control the 
expression of TEs in eukaryotic cells (44). Such example 
of multiple regulations of L1 subtypes has been recently 
demonstrated in human and mouse embryonic stem cells 
(mESCs) (45) (see ‘Regulation in the blastocyst’).
Regulation in the germ cell lineage
The majority of TEs spread in a population according to a 
vertical mode of inheritance (46). This transmission mode 
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Figure 3 Global L1 methylation and 5hmC level during several steps of mammalian development and associated L1 regulatory mechanisms.
(A) Schematic representation of the global L1 methylation level of the mouse genome. During embryonic development, mouse L1 undergoes 
two main waves of demethylation. The first occurs after fertilization: from the zygote stage (0.5 dpc) until the blastocyst stage (3.5 dpc). 
The second occurs during the migration of the PGC precursors from the proximal epiblast to the gonad precursors (from 7.5 to 13.5 dpc). 
PGC, primordial germ cell; NG oocyte, non-growing oocyte. Adapted from ref. (43). (B) Schematic representation of 5-hydromethylcytosine 
dynamics in paternal and maternal genomes during preimplantation development. Adapted from ref. (47).
414      M. Bodak et al.: Mechanisms of L1 regulation in mammals
requires an activity in gamete precursors, making the germ 
line a pertinent developmental context to study L1 regula-
tion. In mice, at 6.5 days postcoitum (dpc), cells from the 
proximal epiblast will differentiate into PGCs and migrate 
to reach the precursor of the gonads. These cells will form 
the germ line. During this process, the early developing 
germ line acquires pluripotency, an event coinciding with 
a relaxation of the epigenetic repression of the genome 
(43) (Figure 3A). This developmental window is indeed an 
opportunity for L1 invasion of the host genome.
Role of DNA methylation
DNA methylation is known to be involved in various 
biological processes as a regulator of gene expression, 
X-chromosome inactivation, genomic imprinting, and 
also in the silencing of TEs (47, 48). The reestablishment of 
the methylation status of L1 elements requires DNA meth-
yltransferase proteins involved in the DNA methylation 
machinery. It has been shown that mutant mouse embryos 
for the maintenance DNA-methyltransferase DNMT1 lose 
the methylation of several types of TEs (49). A similar phe-
notype has been observed for the double-mutant mouse 
for Dnmt3a and Dnmt3b genes encoding for two de novo 
DNA methyltransferases (50).
Studies from Bestor laboratory highlighted yet 
another player in this process: DNMT3L, the DNMT3A 
cofactor that is strictly required for L1 methylation in the 
male germ line (51). DNMT3L stabilizes the active confor-
mation of DNMT3A, thereby increasing the efficiency of 
methyl group transfer onto target site and facilitating de 
novo methylation (52). Problems in completing this proce-
dure involve the high expression level of L1 in germ cells, 
and also sterility, similar to the phenotype observed in 
Dnmt3A and Dnmt3L male mutant mice (51). The Dnmt3L 
gene is also evolutionarily correlated to the germ line pro-
tection against TEs, as it emerged in eutherian mammals 
around 150 million years ago coinciding with an impor-
tant TE expansion in mammalian genomes (53).
Furthermore, proteins assisting the DNA methylation 
process also play a role in TE regulation. For example, 
the protein UHRF1, for ubiquitin-like containing PHD 
and RING finger domains 1, is required by DNMT1 to 
load onto hemimethylated DNA strands. Uhrf1 inactiva-
tion in mice results in decreased methylation of L1 (54). 
The protein lymphoid-specific helicase (LSH) should also 
be mentioned in this context. This member of the SNF2 
family of chromatin remodeling ATPases supports the 
access of DNMTs to the DNA. Initially, LSH was described 
to be directly recruited to L1 elements in mice (55). More 
recently, Meehan laboratory developed a new technology 
called HELP-seq (for HpaII tiny fragment enrichment by 
ligation-mediated PCR coupled to massively parallel DNA 
sequencing) to profile the methylation of TEs in Lsh and 
Dnmt3b mutant fibroblasts (56). They observed hypo-
methylation of L1 in Lsh-/- and Dnmt3b-/- cells, which is 
consistent with previous investigations implicating LSH 
as a recruitment protein for de novo methylation. Nev-
ertheless, they also observed differences of methylation 
between L1 subfamilies and a greater hypomethylation in 
the absence of LSH than DNMT3B, suggesting DNMT3B-
independent roles for LSH in repeat methylation.
Finally, a recent study showed that in addition to DNA 
methylation, the PIWI-interacting RNA (piRNA) pathway 
is required to maintain a high level of repressive H3K9me3 
on L1 elements in mouse germ cells (57).
Role of the piRNA pathway
Studies performed on germ cells from Drosophila depicted 
a new TE repression system based on the interaction of 
piRNA with PIWI proteins (P-element-induced wimpy 
testis) (58). Later, similar complexes have been described 
in the mouse and human germ lines where they play a role 
in the regulation of L1 elements (58).
PIWI proteins belong to the Argonaute superfamily 
(58). Three PIWI proteins have been identified in mice (four 
in humans), MILI, MIWI, and MIWI2, and all are mainly 
germ line restricted (59). In 2006, thanks to the develop-
ment of deep-sequencing techniques, research groups 
identified specific populations of small RNAs binding to 
PIWI proteins: the piRNAs (58). These piRNAs are mainly 
generated from dedicated loci, called piRNA clusters (60), 
consisting of 20–90 kb genomic regions. Around 20% of 
them matched repetitive elements (61), thereby allowing 
to distinguish two kinds of piRNAs: repeat associated and 
non-repeat associated piRNAs. Among the repeat associ-
ated piRNAs, which are mainly derived from retrotrans-
posons, we can set apart primary and secondary piRNAs. 
The one belonging to the piRNA category is length and 
sequence specific: primary piRNAs are about 26 nucleo-
tides (nt) in length, have a uracil nucleotide at position 
1, and correspond to sense-strand transcripts, which 
predominantly associate with MILI protein. Secondary 
piRNAs are 31 nt in length, have an adenine nucleotide at 
position 10, and correspond to antisense strand, bound 
by MIWI2 protein (58). However, this pathway is still not 
entirely understood and several open questions need to 
be addressed. In particular, the initiation of the process 
is not yet fully understood as well as the loading of the 
M. Bodak et al.: Mechanisms of L1 regulation in mammals      415
piRNAs into the PIWI proteins. However, recent studies 
performed in Drosophila have shown that a complex com-
posed of Rhino, Deadlock, and Cutoff (RDC) suppresses 
piRNA cluster transcript splicing and drives piRNA bio-
genesis (62, 63). Other evidences show that MIWI2 loading 
is strictly dependent of MILI SLICING activity (64), and 
that primary and secondary piRNAs are located in distinct 
cytoplasmic compartments. Primary piRNAs loaded on 
MILI supported by the Tudor domain-containing TDRD1 
protein are located in specific organelles named pi-bodies 
(65), whereas secondary piRNAs loaded on MIWI2 sup-
ported by TDRD9 protein are located in distinct compart-
ments named piP-bodies (66). Both complexes have been 
described to be involved in L1 regulation in the germ line 
(67, 68). Mili and Miwi2 mouse mutant males are sterile, 
and L1 transcripts accumulate strongly in their germ line 
(61, 69), phenotypically mimicking the Dnmt3L mouse 
mutant phenotype (70). These similarities suggest that 
the piRNA pathway plays a role in the control of L1 tran-
scriptional output by promoting de novo methylation 
(64). Finally, a study has shown that in Drosophila, Piwi 
exhibits a slicer activity: it can bind single-strand RNA 
and cleave the corresponding RNA target (71). This implies 
that the piRNA machinery could also be involved in the 
post-transcriptional silencing of L1.
Few reports have investigated the role of PIWI-piRNA 
pathways in L1 regulation in humans. The Larriba labora-
tory showed that hypermethylation-associated silencing 
of PIWI2 and TDRD1 is correlated with the hypomethyla-
tion of L1 and linked with spermatogenic disorders. This 
suggests that in humans, PIWI-piRNA pathways could 
also target L1 elements and that the reactivation of such 
TEs could contribute to spermatogenic failures (72).
Regulation in the mature gametes
From 13.5 to 16.5 dpc, the genome of male germ cells under-
goes a wave of remethylation (Figure 3A) (43). Moreover, 
L1 elements of epididymal sperms from adult testis have 
been shown to be fully methylated (73). In contrast, female 
germ cells are never fully methylated (73, 74), whereas sec-
ondary oocytes (ovulated but unfertilized) show an inter-
mediate level of L1 methylation (around 42%) (75) (Figure 
3A). Therefore, L1 are expressed in mature oocytes (76), 
which implies the presence of L1 regulatory mechanisms 
at the oocyte stage other than methylation.
A previous study revealed that exogenously introduced 
target RNAs containing L1 sequences were specifically 
degraded in oocytes by an RNA interference (RNAi)-
dependent mechanism (77), suggesting that in mouse 
oocytes, L1 could be repressed through the RNAi pathway 
(described in ‘RNAi pathways in mammals’). This idea 
was strengthened by the fact that oocytes produce small 
interfering RNAs (siRNAs) derived from L1 sequences (78). 
However, Dicer-deficient mutant oocytes did not show 
any L1 accumulation (78). This last observation could be 
explained by the identification of specific mouse oocyte 
piRNAs (78) (see ‘Role of the piRNA pathway’), which 
could also regulate L1 elements in oocytes.
Moreover, mammal oocytes are blocked at the diplo-
tene stage of meiosis I from the fetal stage until sexual 
puberty. This long meiotic arrest could be an innate 
barrier to the accomplishment of the full L1 retrotrans-
position cycle (Figure 1B). Interestingly, during develop-
ment, oocytes also undergo extensive apoptosis, leading 
to a massive oocytes loss; this process is called fetal 
oocyte attrition (FOA) and is still poorly understood. A 
recent study, however, revealed that enhancement of L1 
expression is involved in the reduction in the number of 
fetal oocytes at birth and that FOA can be modulated by 
controlling L1 activity (79). It is proposed that FOA corre-
sponds to a select mechanism by which only oocytes with 
low L1 activity are conserved (79).
Regulation in preimplantation embryo
Shortly after implantation, at around 6.5 dpc, the mouse 
embryo undergoes a wave of de novo methylation, estab-
lishing a genome-wide hypermethylation pattern (74, 75). 
However, during the development of preimplantation 
embryos, from the zygote to the blastocyst stage, a struc-
ture formed around 2.5 days after fertilization, L1 elements 
are subject to a first wave of demethylation (Figure 3A). 
Indeed, a dramatic reduction of L1 methylation level is 
observed during the sperm-to-zygote transition and then 
methylation progressively decreases to reach 13–23% at 
the blastocyst stage (43, 74). This can lead to L1 transcript 
accumulation in the blastocyst and therefore to retro-
transposition events (80). Moreover, other evidences have 
shown that L1 RNA transcribed in male or female germ line 
could remain competent for integration in the early mouse 
embryo after being carried over by the gametes through 
fertilization in mice (81) and in humans (82). These data 
imply that the preimplantation phase can be considered 
as an aperture favorable for L1 invasion.
DNA methylation during preimplantation
In mammals, DNA methylation occurs at the 5-posi-
tion of cytosine (5mC) and is known to be essential for 
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development and many other biological processes, as a 
transcriptional regulation mechanism and for the mainte-
nance of genome stability (47, 48). Until 5-hydroxymethyl-
cytosine (5hmC) was discovered in mammals in 2009, 
it was the only known DNA epigenetic mark (83, 84). It 
has been shown that the ten-eleven translocation (TET) 
protein family is responsible for the conversion from 
5mC into 5hmC through oxidation (85). This suggests that 
5hmC may serve as an intermediate of DNA demethyla-
tion. As 5hmC is not recognized by the maintenance DNA-
methyltransferase DNMT1 during DNA replication (86), 
it is proposed that the conversion of 5mC to 5hmC leads 
to the restriction of DNA methylation patterns through 
passive DNA demethylation during cell division. Further 
studies showed that TET proteins could oxidize 5hmC to 
produce 5-formylsytosine (5fC) and 5-carboxylcytosine 
(5caC) that can be removed from the genome by a thymi-
dine-DNA glycosylase (87, 88). Evidences suggest that 5fC 
and 5caC might serve as intermediates in an active DNA 
demethylation process, as in Tdg gene knockout mouse, 
leading to increased DNA methylation at certain genomic 
loci (89).
After fertilization, the level of 5hmC of the paternal 
genome increases strongly until the end of the zygote 
stage. Subsequently, it decreases to reach its basic level 
(Figure 3B). Later, during the blastocyst stage, the 5hmC 
level of both paternal and maternal genomes highly 
increases (Figure 3B) (47). Several lines of evidence 
support the notion that TET3 drives the 5mC oxidation 
during preimplantation and also DNA demethylation: 
(i) during the same time window (from zygote to blasto-
cyst stage), an increase of the 5hmC level and a decrease 
of the global L1 methylation level are observed (Figure 3A); 
(ii) TET3 is highly expressed at the zygote stage (90); and 
(iii) Tet3 siRNA-mediated knockdown abolishes 5mC oxi-
dation (91). Nonetheless, the role of 5hmC in the regula-
tion of TEs still needs to be further investigated.
However, a recent report describes a gonad-specific 
expression gene (GSE) to be present specifically in germ 
cells and in preimplantation embryos. This protein is 
localized in the nuclei of cells from the zygote to the 
blastocyst stage (92). Zygote GSE knockdown mediated 
by antisense RNA results in an increase in LINE-1 meth-
ylation level and reduction of 5mC to 5hmC on L1 (92), 
suggesting an active DNA demethylation role for GSE 
during zygote development and a role of 5hmC in LINE-1 
regulation.
Finally, two recent articles described the methyla-
tion profile during human and mouse early development 
(93, 94). These studies reveal that the global methylation 
reprogramming after fertilization is globally conserved. 
Nonetheless, L1 with different evolutionary ages show 
different demethylation patterns: young L1 elements are 
more resistant to demethylation than their older counter-
parts in human embryos (93).
RNAi pathways in mammals
In several organisms, RNAi pathways are used as a post-
transcriptional mechanism for TE repression (95). Three 
major classes of endogenous small RNAs have been first 
identified in mammals: microRNAs (miRNAs), piRNAs, 
and endogenous siRNAs (endo-siRNAs) (58). While 
miRNAs and siRNAs are loaded into the AGO effector 
proteins, piRNAs interact only with the PIWI proteins, 
expressed mainly in germ cells (see ‘Role of the piRNA 
pathway’) (58).
Dicer promotes processive cleavage of double-
stranded RNAs into endo-siRNAs (96) that are loaded into 
AGO2 to mediate endonucleolytic cleavage of their target 
transcript. miRNAs have been identified as important 
post-transcriptional regulators of gene expression (97). 
Most animal miRNAs are transcribed in the nucleus by 
RNA polymerase II as stem-loop long primary transcripts 
(pri-miRNA). Following transcription, they are processed 
sequentially in the nucleus and cytoplasm by a complex 
of RNAse-III endonucleases: DROSHA and DICER. Spe-
cifically, DROSHA and its partner DGCR8, which repre-
sent what we call ‘the microprocessor complex’, process 
the pri-miRNA transcript to a 70–93 nt stem-loop precur-
sor RNA (pre-miRNA). Subsequently, they are delivered 
to the cytoplasm by Exportin 5, where they are cleaved 
by a non-processive DICER, which forms a complex with 
TRBP, to produce an ∼22 nt miRNA-3p:miRNA-5p duplex 
(canonical pathway). Once in the cytoplasm, one of the 
duplex strands (miRNA-3p or miRNA-5p) is preferentially 
incorporated into the RNA-induced silencing complex 
(RISC) in association with an AGO family member. Within 
the RISC-AGO entity, the miRNA guides the complex to its 
RNA target, thereby mediating its repression. In animals, 
miRNAs control gene expression by binding to the 3′UTR 
of their target genes through Watson-Crick base pairing 
between the target and the 5′-end of the miRNAs: the 
‘seed’ sequence (nt 2–8). Furthermore, the Microproces-
sor is directly involved in the regulation of L1 elements in 
humans (described in ‘Regulation in the blastocyst’) (38).
Finally, recent technical developments have enabled 
the identification of a multitude of novel types of small 
RNA molecules that do not fit into the well-established 
classes (35, 98). Moreover, RNAi pathways expand beyond 
the post-transcriptional regulation, by having a role in the 
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maintenance of cellular integrity (35) and by acting as an 
antiviral defense mechanism (99).
A shift of the small RNA balance during preimplantation
After fertilization, the first event of gene expression is 
called zygotic gene activation. It takes place at the two-
cell stage in mice and at the four-cell stage in humans, 
and has been involved in qualitative and quantitative 
changes in coding and non-coding gene expression 
(100, 101). In zebrafish, an miRNA (miR-430) has been 
involved in the deadenylation and the clearance of mater-
nal mRNAs (102). This result and the development of 
sequencing technologies have encouraged researchers to 
profile small RNAs during mouse early development from 
mouse unfertilized (metaphase II: MII) oocytes, 8–16-cell 
stage embryos to the blastocyst stage (103). This study 
revealed a switch in small RNA populations from siRNA 
and piRNA derived from retrotransposons to the tran-
scription of miRNAs (103).
How and why this change in small RNA populations 
occurs still needs to be further investigated. Recently, it 
has been shown that the processivity of DICER, the key 
enzyme in siRNA and miRNA pathways, decreases during 
early development (104), which could explain the switch 
between siRNA to miRNA populations. The decrease of 
the piRNA population correlates with the first wave of 
demethylation of the genome (see ‘DNA methylation 
during preimplantation’), suggesting a cooperative role of 
piRNA and methylation pathways.
L1 mRNAs have been recently monitored by RNA-seq 
and RT-qPCR from the two-cell stage to the blastocyst stage 
(105). This work revealed that L1 are reactivated after fer-
tilization and intensively transcribed at the two-cell stage 
embryo; however, their expression strongly decreases until 
the eight-cell stage and is maintained at a low level until 
the blastocyst stage, suggesting the existence of an active 
and fast repression of L1 elements during preimplanta-
tion. However, little is known about the regulation of L1 
during early development. The expression profiles of the 
Piwi family genes indicated that MILI protein is transiently 
expressed at the eight-cell stage (103), suggesting the pos-
sibility of a regulation through the piRNA pathway. In con-
trast, experiments performed on fertilized 1- and 8–16-cell 
embryos, involving the introduction of GFP RNAs carrying 
L1 sequences and the monitoring of the target RNA degra-
dation, revealed a specific degradation of the target RNAs 
at both stages: 1-cell and 8–16-cell embryo (103). Finally, 
maternally derived L1 small RNAs also appeared to be 
active to at least the 8–16-cell stage (103).
Regulation in the blastocyst
The hypomethylated status of L1 elements (75), the lack of 
piRNAs (103), and the ability of engineered L1 to integrate 
during embryogenesis (81) turn the blastocyst stage into a 
critical window for L1 regulation. mESCs are pluripotent 
stem cells derived from the inner cell mass of blastocysts. 
They can be maintained undifferentiated under controlled 
culture conditions or induced into the three primary germ 
layers, therefore representing a useful model to mimic 
in vitro early development.
Profiling of small RNAs from mESCs revealed the pres-
ence of miRNAs and some endogenous siRNAs derived 
from repeated elements (106, 107), but not piRNAs. These 
observations bring them up as a suitable model to study 
the mechanism that might regulate L1 expression and ret-
rotransposition during the last step of preimplantation 
development.
Both human and mouse L1 5′UTR contain sense and 
antisense promoters. This bidirectional transcription of 
L1 5′UTR has the potential to generate specific double-
stranded RNAs, which could be a perfect substrate for 
Dicer (34–36). Moreover, experiments in human cultured 
cells have shown that the RNA transcribed from the 5′UTR 
antisense promoter induces post-transcriptional mRNA 
degradation of the 5′UTR sense derived transcript through 
RNAi, suggesting a role of DICER in the regulation of L1 
elements in human cells (108). Experiments performed in 
Dicer knockout mESCs showed an upregulation of mRNAs 
and ORF1 protein derived from L1, hypomethylation of 
the 5′UTR, and a gain of L1 copy number in the genome 
(35). These observations, combined with the fact that 
Ago knockout mESCs also shows an upregulation of L1 
transcripts and an increase of L1 copy number (35), dem-
onstrate that the siRNA pathway is involved in the L1 regu-
lation in mESCs and probably also at the blastocyst stage 
of the mouse embryos.
Other evidences suggest the involvement of another 
actor of the RNAi pathway in the regulation of human 
L1 element: the microprocessor. It has been shown that 
the Microprocessor is able to bind L1-derived RNAs, to 
regulate the level of L1 mRNAs and ORF1 protein, and to 
cleave in vitro the 5′UTR of L1 mRNAs (38). In the proposed 
model, the microprocessor restricts L1 retrotransposition 
at a post-transcriptional level by binding L1 mRNAs within 
the nucleus and cleaving hairpin structures contained in 
the L1 5′UTR (Figure 2C). This process has the potential 
to destabilize L1 transcripts and decrease the produc-
tion of L1 proteins, and finally to reduce retrotransposi-
tion (38). A similar process has already been described for 
regulation at the human immunodeficiency virus (HIV) 
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type 1 promoter (109), where it was reported that the 
microprocessor can cleave the nascent RNA and gener-
ate an uncapped transcript. This uncapped RNA serves 
as a signal for the recruitment of a termination factor that 
degrades the ongoing transcript, leading to the termina-
tion of transcription (109).
Recently, a study from the Trono laboratory demon-
strated that a specific subset of L1 elements is repressed by 
the KAP1 protein, a KRAB-containing zinc finger protein 
cofactor, in human ESCs. Moreover, the mutation of this 
gene in mESCs reactivates the expression of old L1 elements 
(45). The authors proposed an evolutionary model in which 
newly emerged L1 lineages are first repressed by DNA meth-
ylation before being taken over by a KAP1 protein-mediated 
silencing process (45). This model is consistent with the 
observation made in human early embryos by the Qiao 
laboratory (93), which described that young L1 elements 
are more resistant to demethylation that their older coun-
terparts (see ‘DNA methylation during preimplantation’).
Finally, a recent report from the Junewein laboratory 
demonstrated that heterochromatin is required to restrict 
the aberrant expression of TEs and that Suvar39 histone 
methyltransferase is important for the silencing of L1 type 
A in mESCs (110).
However, it must be remembered that mESCs and 
human ESCs are not equivalent: they use different signal-
ing pathways to maintain their pluripotency and diverge 
at the epigenetic state (111). Data obtained on LINE-1 ele-
ments in mESCs are not necessarily applicable to human 
L1 and vice versa. Moreover, several reports based on tran-
scriptome analyses proposed that human ESCs are more 
closely related to post-implantation mouse epiblast stem 
cells than to mESCs (111, 112).
Regulation in somatic cells
DNA methylation patterns are established during embry-
onic development by de novo methylated enzymes, 
DNMT3A and DNMT3B (see ‘Role of DNA methylation’). In 
mammals, this methylation at 5mC is mainly maintained 
by the maintenance DNA methyltransferase DNMT1 (48). 
Moreover, this epigenetic modification can inactivate 
genes by direct exclusion of the transcriptional machinery 
from methylated promoter DNA. It acts by directly imped-
ing the binding of transcriptional factors to their target 
sites, and altering chromatin structure through histone 
modification and nucleosome occupancy within the pro-
moter regions of genes (48).
The implication of DNA methylation in regulating L1 
expression originates from multiple studies. In various 
cell lines, the expression of L1 full-length transcripts is 
correlated with the differential methylation level of the 
promoter region (47, 48). In somatic cells, few or no L1 pro-
teins are expressed, and most L1 elements are fully meth-
ylated. On the contrary, a full-length RNA signal becomes 
detectable if methylation is inhibited, and the level of 
5′UTR-containing transcripts is increased in cultured cells 
(113, 114). However, DNA methylation is not the only L1 
regulatory mechanism present in somatic cells, and in 
the following section we will also focus on the role of RNA 
editases in L1 element repression.
L1 methylation in somatic tissues
Cell-based reporter assays performed in human cells 
showed that L1 promoter activity is significantly inhibited 
by CpG methylation and that only a subset of these CpG 
sites affects L1 promoter activity in an in vitro transcription 
assay when mutated (115). Methylated CpG sites are rec-
ognized by members of the methyl-CpG-binding domain 
(MBD) protein family, which in turn recruit histone 
de acetylases and generate transcriptionally inactive chro-
matin structures (116). Reporter assays have shown that 
methyl-CpG-binding protein 2 (MeCP2), the founding 
member of the MBD family, can bind to methylated L1 
5′UTR and represses its transcription (117, 118).
The characterization of L1 5′UTR made it possible to 
specifically investigate the methylation status of L1 pro-
moters, and a large number of CpG sites in L1 5′UTR have 
been surveyed by bisulfite sequencing (119). In general, 
the methylation patterns of the 5′UTR during development 
are consistent with those of the body of L1. Finally, it has 
been shown that the body of endogenous L1 is fully meth-
ylated in somatic tissues such as the brain, kidney, liver, 
and spleen (75).
Role of the RNA editases
RNA editing is a molecular process that allows the modi-
fication of the information content in an RNA molecule 
by switching nucleotide sequences, usually cytidine into 
uridine (C to U) or adenosine into inosine (A to I) (120). 
RNA-dependent deaminases are the enzymes responsible 
for the base deamination process. By altering the RNA, 
and consequently the amino acid sequence of encoded 
proteins, RNA editing plays an important role in expand-
ing the genome capacity. Mutant mouse models for such 
enzymes show immunity issues and susceptibility to viral 
infection (121), suggesting that RNA-editing proteins are 
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involved in innate immune responses against infectious 
RNA viruses. As RNA editases can act against invading 
RNA particles, they can also be potential inhibitors of TEs.
Among them, we can highlight the APOBEC protein 
family that catalyzes the deamination of cytosine resi-
dues into uracils. It has been shown that one member, 
APOBEC3G, can reduce the replication of HIV by inducing 
uracil mutation accumulation on the retroviral comple-
mentary strand, and thus inactivating the newly inte-
grated copy (122). Additionally, retrotransposition assay 
experiments have highlighted APOBEC3A and APOBEC3B 
as potent inhibitors of retrotransposons (123). Recent work 
from the Moran laboratory demonstrated that APOBEC3A 
can inhibit L1 retrotransposition by deaminating tran-
siently exposed single-stranded DNA that arises during 
new L1 integration events (124). Similarly, the activation-
induced deaminase (AID) protein is also able to inhibit L1 
retrotransposition, through a mechanism independent 
from deamination (125) and not yet understood. It has 
been hypothesized that this family mediates cytoplasmic 
sequestration of L1 RNA and/or L1-encoded proteins, or 
inhibits the activity of L1 ORFs (126).
The special case of the neuronal progenitor cells
The neural stem cells residing in the neurogenic regions 
of the brain have the abilities to remain multipotent, rep-
licate, and differentiate into glial progenitors or neuronal 
progenitor cells (NPCs). L1 promoters are highly methyl-
ated in neural stem cells, and MeCP2 is recruited for their 
repression (117, 118). However, it has been observed that 
not only L1 expression increases upon the NPC differen-
tiation (127) but also that L1 can retrotranspose in human 
and mouse NPCs in vitro (127, 128). These L1 integration 
events lead to an alteration of the expression of neigh-
boring genes by promoter enhancement and epigenetic 
silencing (127), which could affect neuronal fate and func-
tion. The details of these retrotransposition events and 
their possible consequences have been recently reviewed 
(129). This unique ability of L1 to retrotranspose in NPCs 
could be explained by its repression mechanism involving 
the TF sex determining-region Y-box 2 (Sox2). It has been 
shown that the L1 promoter contains several TF binding 
sites, including a Sox2 site (130). This key factor is involved 
in the maintenance of the multipotency and the prolifera-
tive state of neural stem cells (131). However, Sox2 is also 
involved in the inhibition of L1 expression in neural stem 
cells by forming a repressor complex and associating with 
the L1 promoter (127). When neural stem cells commit to 
the neuronal lineage, Sox2 expression decreases, repressor 
complexes dissociate, and L1 promoter methylation level 
drops (127), thus explaining the high expression of L1 in 
NPCs. Interestingly, the promoter region of a major TF pro-
moting neurogenesis, NeuroD1, harbors a Sox2 binding 
domain similar to the L1 5′UTR (129). Hence, expression 
of NeuroD1 and L1 could follow the same pattern during 
neurogenesis, explaining the high L1 expression during 
neuronal differentiation. Finally, a study has shown 
enrichment of 5hmC in Purkinje neurons (83). As we have 
previously explained (see ‘DNA methylation during pre-
implantation’) that this epigenetic mark is related to DNA 
demethylation and therefore to the relaxation of L1 repres-
sion, this observation could explain the higher sensitivity 
of neuronal precursors to L1 mobilization.
Other LINE-1 regulators described in somatic cells
Numerous studies performed on human cell lines have 
recently revealed new putative L1 regulators (132). Here, 
we present some newly described examples in the lit-
erature. An RNA helicase, the MOV10 protein, has been 
shown to be able to inhibit retrotransposition (133). MOV10 
is able to associate with the L1 RNP particle and reduces 
L1 retrotransposition activity when it is overexpressed in 
human cell lines (133). The role of MOV10 as a potential 
L1 inhibitor is strengthened by the significant increase 
of L1 retrotransposition events in MOV10-depleted cells. 
However, the inhibitory mechanism involving MOV10 is 
still unclear. MOV10 has been shown to interact with the 
RISC, indicating that RNAi pathways could be involved in 
L1 regulation in human cell lines. In mice, MOV10-like-1, 
the testis specific paralogue of MOV10, is able to bind the 
piRNA-associated proteins MILI and MIWI (134). Finally, 
in the testis of Mov10-like-1 knockout mice, an upregula-
tion of L1 mRNA has been observed (134), suggesting a 
role of piRNA pathway in L1 repression.
The work of the Martin laboratory has highlighted 
other classes of L1 repressors such as the heterogene-
ous nuclear RNPs (hnRNPs), which are composed of four 
members: R, Q, L, and nucleolin (NLC) (135). In their 
study, the authors performed an hnRNPL knockdown in 
human cell lines and observed a significant increase of 
ORF1p level, L1 mRNA level, and a 10-fold increase of L1 
retrotransposition events, implying a role of hnRNPL as a 
potent negative regulator of L1 in human cell lines (135). 
On the contrary, depletion of NLC leads to a decrease of 
L1 retrotransposition rate by about 10-fold, designating 
NLC as a positive actor in the L1 retrotransposition process 
(135). As hnRNPL plays multiple roles in RNA metabolism 
and no effect on the L1 mRNA processing was observed 
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in the depleted cells, the research team hypothesized that 
hnRNPL acts as defense factor by decreasing the L1 mRNA 
and therefore the level of RNP available for the final step 
of the retrotransposition cycle.
Furthermore, in human cells, Boeke’s team showed 
that two poly(A) binding proteins (PABPs), PABPN1 and 
PABPC1, can affect the L1 retrotransposition activity (136). 
They proved that both of them are associated with L1 RNP 
complexes, probably through the ability of both proteins 
to bind the L1 mRNA. Moreover, knockdown experiments 
of the corresponding mRNA result in significant reduc-
tion of L1 retrotransposition rate. By opposition, in PAIP2 
knockdown cells, an inhibitor of PABPC1, a 2-fold L1 ret-
rotransposition increase has been observed (136). Taken 
together, these results suggest that PABPC1 is essential for 
the formation of the RNP, and any depletion of PABPC1 can 
lead to defect in the RNP formation and in the achieve-
ment of a retrotransposition cycle (136). As it is known 
that PABPC1 can shuttle between the cytoplasm and the 
nucleus, the authors assumed that PABPC1 might provide 
a direct trafficking function for the RNP nuclear translo-
cation, an essential step to complete a retrotransposition 
cycle (136).
Finally, another study proposes the 3′ repair exonucle-
ase Trex-1 as a potent regulator of L1 (137). Trex-1 is a nega-
tive regulator of the interferon-stimulatory DNA pathway, 
a cell-intrinsic antiviral response activated by cytosolic 
DNA detection. An accumulation of single-stranded 
DNA fragment derived from endogenous retroelements is 
observed in Trex-1-deficient cells, and it has been shown 
that Trex-1 can metabolize specifically reverse-transcribed 
DNA of endogenous retroelements (137). These evidences 
suggest a connection between retroelements and the 
interference DNA signaling (IDS) pathway. However, the 
mechanism of metabolization remains unclear.
LINE-1 in cancers
The hypomethylation status of L1 5′UTR in malignant 
cells has been correlated with the L1 expression levels, 
and numerous cancers showed distinct L1 activation. 
What is known about L1 activity during oncogenesis and 
tumor progression has already been reviewed intensively 
recently (138, 139), and we refer to these articles for more 
details. However, even if a reactivation of L1 is observed 
in such tissues, a crucial question remains elusive: is 
L1 mobilization a cause or a consequence of cancer 
progression?
In this line of idea, a recent study analyzed 290 cancer 
samples from 244 patients across 12 tumor types and 
revealed that most retrotransposition events are harm-
less, arguing in favor of the fact that a huge amount of L1 
 retrotransposition will be a consequence of tumorigenesis 
(140).
Challenges in analyzing the 
 epigenetic status of repeat 
elements
Chromatin immunoprecipitation followed by sequenc-
ing (ChIP-seq) has become a gold standard technique to 
genome-wide profiling of chromatin signatures, including 
DNA-binding proteins and histone modifications. Up to 
date, vast amounts of ChIP-seq data have been generated, 
focusing mainly on the epigenetic patterns of genes, pro-
moters, and enhancers, but not TEs (141), thereby leaving 
this area largely unexplored (142).
Usually, ChIP-seq data analysis can be divided into 
the following steps: quality control, read mapping, peak 
calling, peak annotation, and motif identification (143). 
For each step, algorithms have been well developed and 
a series of bioinformatic software are available (142). 
However, the main challenge in analyzing ChIP-seq data 
on TEs is still how to allocate multiple-hit reads (MHRs; 
i.e., reads that could be mapped to several equally good 
positions). The small size of next-generation sequencing 
reads (36–50 bp with the first generation of deep-sequenc-
ing machines) and the huge amount of repeat elements in 
the genome are therefore the main issues. In this part, we 
discuss two different strategies already used to annotate 
reads on L1 and compare their pros and cons.
Mapping on consensus sequences
One solution to avoid, but not directly solve, this 
problem is to identify the peaks at the level of the con-
sensus sequence for each repeat type or family, and not 
on the genome sequences (105, 144, 145). For example, 
instead of discarding all MHRs, Day et al. (144) kept the 
reads that could be mapped to the same or similar repeat 
type using a phylogenetic approach. By implementing 
this method with histone modification ChIP-seq dataset 
from mouse cell lines, they achieved a 10-fold increase of 
read usage for repeat elements. Indeed, the authors iden-
tified distinct histone modification patterns between 
endogenous retrovirus (ERV)-K and ERV1 subfamilies, 
in a subtype of LTR retrotransposons. It will now be 
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interesting to implement this method for other kinds of 
repeats, to investigate their epigenetic pattern. However, 
as the enrichment estimation is based on a consensus 
repeat sequence, other approaches are still needed to 
investigate the epigenetic pattern in every individual 
repeat element in the genome.
Using computational approaches to rescue 
MHRs
A more direct way to address MHRs is to allocate them into 
potential regions according to known information, e.g., 
the number of unique-hit reads (UHRs). A similar strategy 
is currently used for isoform quantification from RNA-seq 
data and could be addressed using similar algorithms 
implemented in CuffLink (146) and RSEM (147). This type 
of methods could rescue all MHRs, which are usually fil-
tered out in ChIP-seq data analysis. For example, Chung 
et  al. (148) conducted an expectation-maximization 
algorithm to allocate the MHRs to each potential region 
according to the count of UHRs. By implementing this 
algorithm for STAT1 and GATA1 ChIP-seq libraries in 
human and mouse cells, they identified up to 35% novel 
binding sites, most of them being located in repeat ele-
ments and segmental duplications (148). More recently, 
Wang et al. (149) also developed an empirical formula to 
distribute MHRs according to two factors: the distance of 
MHR to its nearest peak identified by UHR and the enrich-
ment score of the peak. They implemented this algorithm 
to several datasets, including DNA methylation, histone 
modifications, and TF binding, and identified up to 60% 
new peaks (138).
Strategies remain imperfect
However, all these methods rely on assumptions, which 
could be not true. For example, the distribution of 
UHRs may not reflect the true binding preference of a 
TF and thus will mislead the allocation of MHRs. Also, 
an empirical formula derived from one experimental 
design may not fit another setup. The current approach 
in the field of TEs to address this problem is to increase 
the read size (100–200 bp) and use a paired-end library, 
or even develop new experimental protocols that could 
specifically capture repeat elements (110, 138). Besides, 
special attention should be paid when mapping reads to 
species with only draft genome (e.g., sloth and tarsier), 
where the annotation of repeat elements is far from 
comprehensive.
Expert opinion
In this review, we tried to provide an overview about what 
is known concerning the regulation of the most repre-
sented TE in the mouse and human genomes. Taking into 
account the high mutagenic potential of L1, due to their 
ability to ‘jump’, specific repressive mechanisms have 
been established in mammals to prevent invasion by these 
mobile elements during the life cycle. First, we compared 
the L1 elements from the two major models used for their 
study: the mouse and the human L1. We showed that 
even if they share common features, they also differ in 
their mobilisation activity and at the structure level, par-
ticularly of the 5′UTR, a key region for the expression and 
mobilization of L1. The differences observed between the 
predicted secondary structures of mouse and human L1 
5′UTR (Figure 2C) could involve the existence of different 
L1 regulatory mechanisms between this two species. This 
implies that results derived from studies performed with 
human L1 constructs in mouse or vice versa should be con-
sidered with more caution.
Subsequently, we presented the major L1 defense 
mechanisms currently described in the literature. We 
showed that over the life cycle of a mammalian indi-
vidual, a range of mechanisms regulate the remaining 
L1 active copies present in the genome. In somatic cells, 
studies revealed a potential role of RNA editases in the 
repression of L1. However, DNA methylation seems to be 
the main regulatory mechanism in somatic cells to ensure 
transcriptional repression of these mobile elements. 
During embryonic development, mammals undergo two 
waves of demethylation, thus establishing windows of 
opportunity for L1 expression and retrotransposition. The 
first wave starts at the zygote stage and continues until 
the blastocyst stage (Figure 3A). It has been shown that 
L1 are reactivated and expressed just after fertilization; 
however, this expression rapidly decreases as develop-
ment progresses. Little is known about the L1 regulation 
during early embryonic development. However, evi-
dences indicate that RNAi pathways are involved. In addi-
tion, further results suggest that piRNA could be involved 
before the blastocyst stage. During the blastocyst stage, 
owing to the lack of piRNAs, other models have been pro-
posed to explain L1 regulation involving the Microproces-
sor complex, which could directly bind and cleave human 
L1 transcripts. Alternatively, DICER protein and the siRNA 
pathway are involved in mice. The previous model is sup-
ported by the presence of sense and antisense promoters 
in L1 5′UTR of both humans and mice, which have the 
potential to generate specific double-stranded RNAs that 
are suitable substrates for DICER.
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Later during development, the second wave of 
demethylation occurs during the migration of the PGC 
precursor cells (Figure 3A). During this phase, the piRNA 
pathway seems to be the major L1 regulatory mechanism. It 
is suggested that the PIWI proteins, by loading L1 piRNAs, 
could not only promote specific de novo methylation but 
also cleave the corresponding target. This implicates that 
the piRNA pathway could regulate L1 at two levels: tran-
scriptional and post-transcriptional. However, how the 
piRNAs are loaded into the PIWI proteins or how the PIWI 
proteins could recruit the de novo methylation machin-
ery are still not understood and remain the major ques-
tions in this field. At the level of the mature gamete, the 
piRNA pathway has been proposed to maintain L1 repres-
sion in oocytes considering the low level of methylation of 
its genome compared with the male gamete. Recently, a 
publication has highlighted the FOA as a possible process 
of selecting suitable oocytes by eliminating the female 
gamete possessing a high level of L1 activity.
Finally, we discussed the challenge in studying the 
epigenetic mechanisms of such repeat elements. Because 
of the small size of reads generated from ChIP-seq experi-
ments, accurate mapping is not possible, although several 
state-of-art computational methods have been developed. 
Compromises have to be made in this situation, either by 
mapping reads to consensus sequence, or trying to esti-
mate the MHRs under some assumptions.
Outlook
According to the remaining questions raised in the ‘Expert 
opinion’ section, future studies should focus on the 
mechanisms driving the piRNA pathway. In particular, the 
studies should investigate the generation of the piRNAs, 
the loading of these piRNAs into the PIWI proteins, and 
the possible recruitment of the de novo methylation 
machinery by the PIWI proteins.
The regulation of L1 during preimplantation develop-
ment should also be further investigated. The develop-
ment of new genetic screens in mammals, thanks to the 
establishment of the haploid stem cell system, could be 
a system to discover new actors in L1 regulation. More-
over, the revolution at the genome engineering level with 
the discovery and the development of the CRISPR/Cas9 
system in mammalian cells should be used to manipulate 
the L1 expression level in all cell types, both in vitro and 
in vivo.
Furthermore, it has also been shown that mobile 
elements are responsive to stress; however, this area is 
understudied and should be addressed further in the 
future. A good example is the effects of hypoxic stress, 
which are frequently associated with cancer progression 
and have been recently linked to an overrepresentation of 
SINEs in blind mole rats (150).
Highlights
 – L1 elements are regulated by a large range of mech-
anisms during the mammalian life cycle. These 
mechanisms are supposed to overlap to reinforce L1 
repression. However, the question of recognition still 
remains: how are L1 elements initially recognized and 
triggered?
 – Similarly, the question concerning the origin of L1 
remains elusive. Consequently, the questions linked 
to the establishment of host defense mechanisms, the 
evolutionary strategies used by mobile elements to 
get past these mechanisms, as well as the arm race 
between jumping elements and the host organism are 
still unsolved and need to be investigated.
 – The question of the biological significance also sub-
sists. Do L1 have a biological role or can we just con-
sider them as parasites tempting to expand in the host 
genome? Some evidences suggest that L1 are required 
for cell differentiation and early development.
 – L1 reactivation has been observed in cancer cells or 
tissues. However, it is still not possible to determine 
if this reactivation is the cause or a consequence of 
the cancer.
 – Finally, the factors making some L1 prone to activation 
and reactivation need to be investigated more deeply. 
Stem cells and NPCs have specific epigenetic status 
that could explain L1 activation. Indeed, studies of 
different pluripotent cell lineages could be particu-
larly interesting to better understand L1 regulation.
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